Literature DB >> 28108776

[Levosimendan-no effect on multiorgan failure in septic shock].

U Janssens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28108776     DOI： 10.1007/s00063-016-0248-7

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN： 2193-6218            Impact factor:   0.840


× No keyword cloud information.
  14 in total

Review 1.  [If the myofilaments become sensitive: Ca2+-sensitizer for the therapy of heart insufficiency].

Authors:  R H Schwinger; K Brixius
Journal:  Dtsch Med Wochenschr       Date:  2005-04-15       Impact factor: 0.628

Review 2.  [Cardiovascular dysfunction in sepsis].

Authors:  Uwe Janssens; Jürgen Graf
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2008-01       Impact factor: 0.698

3.  Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis.

Authors:  Anthony C Gordon; Gavin D Perkins; Mervyn Singer; Daniel F McAuley; Robert M L Orme; Shalini Santhakumaran; Alexina J Mason; Mary Cross; Farah Al-Beidh; Janis Best-Lane; David Brealey; Christopher L Nutt; James J McNamee; Henrik Reschreiter; Andrew Breen; Kathleen D Liu; Deborah Ashby
Journal:  N Engl J Med       Date:  2016-10-05       Impact factor: 91.245

4.  [Levosimendan for septic shock with takotsubo cardiomyopathy].

Authors:  C-N Schlürmann; J Reinöhl; J Kalbhenn
Journal:  Anaesthesist       Date:  2016-01       Impact factor: 1.041

5.  Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock.

Authors:  F Jardin; T Fourme; B Page; Y Loubières; A Vieillard-Baron; A Beauchet; J P Bourdarias
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 6.  Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.

Authors:  Alberto Zangrillo; Alessandro Putzu; Fabrizio Monaco; Alessandro Oriani; Giovanna Frau; Monica De Luca; Nora Di Tomasso; Elena Bignami; Vladimir Lomivorotov; Valery Likhvantsev; Giovanni Landoni
Journal:  J Crit Care       Date:  2015-05-29       Impact factor: 3.425

7.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

Authors:  Alexandre Mebazaa; Markku S Nieminen; Milton Packer; Alain Cohen-Solal; Franz X Kleber; Stuart J Pocock; Roopal Thakkar; Robert J Padley; Pentti Põder; Matti Kivikko
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

8.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

Review 9.  Sepsis and the heart.

Authors:  J D Hunter; M Doddi
Journal:  Br J Anaesth       Date:  2010-01       Impact factor: 9.166

10.  An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.

Authors:  Robert M L'E Orme; Gavin D Perkins; Daniel F McAuley; Kathleen D Liu; Alexina J Mason; Andrea Morelli; Mervyn Singer; Deborah Ashby; Anthony C Gordon
Journal:  Trials       Date:  2014-06-02       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.